Beam Therapeutics Presents New Non-Human Primate (NHP) Data Demonstrating Proof-Of-Concept For ESCAPE, A Non-Genotoxic, Antibody-Based Conditioning Approach To Treating Sickle Cell Disease, At American Society Of Hematology (ASH) Annual Meeting
Beam Therapeutics Presents New Non-Human Primate (NHP) Data Demonstrating Proof-Of-Concept For ESCAPE, A Non-Genotoxic, Antibody-Based Conditioning Approach To Treating Sickle Cell Disease, At American Society Of Hematology (ASH) Annual Meeting . (MENAFN - EIN Presswire) 
 
  NHP Data Showed CD117 Monoclonal Antibody (mAb) Conditioning Successfully Achieved Long-term Engraftment of Base-edited Hematopoietic Stem Cells and Induced Robust ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108968801/Beam-Therapeutics-Presents-New-Non-Human-Primate-NHP-Data-Demonstrating-Proof-Of-Concept-For-ESCAPE-A-Non-Genotoxic-Antibody-Based-Conditioning-Approach-To-Treating-Sickle-Cell-Disease-At-American-Society-Of-Hematology-ASH-Annual-Meeting
2024-12-08
rss
(MENAFN - EIN Presswire) 
 
  NHP Data Showed CD117 Monoclonal Antibody (mAb) Conditioning Successfully Achieved Long-term Engraftment of Base-edited Hematopoietic Stem Cells and Induced Robust ...
Beam Therapeutics Presents New Non-Human Primate (NHP) Data Demonstrating Proof-Of-Concept For ESCAPE, A Non-Genotoxic, Antibody-Based Conditioning Approach To Treating Sickle Cell Disease, At American Society Of Hematology (ASH) Annual Meeting